1. Home
  2. SSTK vs AVXL Comparison

SSTK vs AVXL Comparison

Compare SSTK & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSTK
  • AVXL
  • Stock Information
  • Founded
  • SSTK 2003
  • AVXL 2004
  • Country
  • SSTK United States
  • AVXL United States
  • Employees
  • SSTK N/A
  • AVXL N/A
  • Industry
  • SSTK EDP Services
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SSTK Technology
  • AVXL Health Care
  • Exchange
  • SSTK Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • SSTK 682.2M
  • AVXL 779.5M
  • IPO Year
  • SSTK 2012
  • AVXL N/A
  • Fundamental
  • Price
  • SSTK $18.67
  • AVXL $8.58
  • Analyst Decision
  • SSTK Buy
  • AVXL Strong Buy
  • Analyst Count
  • SSTK 4
  • AVXL 2
  • Target Price
  • SSTK $45.33
  • AVXL $44.00
  • AVG Volume (30 Days)
  • SSTK 512.3K
  • AVXL 1.0M
  • Earning Date
  • SSTK 05-01-2025
  • AVXL 05-08-2025
  • Dividend Yield
  • SSTK 7.07%
  • AVXL N/A
  • EPS Growth
  • SSTK N/A
  • AVXL N/A
  • EPS
  • SSTK 1.01
  • AVXL N/A
  • Revenue
  • SSTK $935,262,000.00
  • AVXL N/A
  • Revenue This Year
  • SSTK $13.87
  • AVXL N/A
  • Revenue Next Year
  • SSTK $4.32
  • AVXL N/A
  • P/E Ratio
  • SSTK $18.49
  • AVXL N/A
  • Revenue Growth
  • SSTK 6.94
  • AVXL N/A
  • 52 Week Low
  • SSTK $17.17
  • AVXL $3.25
  • 52 Week High
  • SSTK $46.46
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • SSTK 29.84
  • AVXL 41.53
  • Support Level
  • SSTK $19.20
  • AVXL $9.21
  • Resistance Level
  • SSTK $20.05
  • AVXL $9.87
  • Average True Range (ATR)
  • SSTK 0.78
  • AVXL 0.54
  • MACD
  • SSTK 0.19
  • AVXL -0.06
  • Stochastic Oscillator
  • SSTK 43.48
  • AVXL 10.50

About SSTK Shutterstock Inc.

Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

Share on Social Networks: